FDA Investigator Melba T Rivera
Melba T Rivera has inspections in 1 countries as of 06 May 2022. Melba T Rivera has collaborated with a combined 1226 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
06 May 2022
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alberto A Viciedo,
Allen Lou,
Amy L Singer,
Ana S Cabrera,
Ann Marie Montemurro,
Barbara J Wilimczyk,
Barbara Jwilimczyk Macri,
Barbara L Rellahan, PhD,
Cara M Minelli,
Carl A Perez,
Cary Greene,
Charles J Chacko,
Daniel J Grabicki,
David H Smith,
Deborah B Nixon,
Douglas C Kovace,
Douglas C Kovacs,
Dr. Zhou Chen (nmi), MD PhD,
Eileen A Liu,
Emest F Bizjak,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Frank J Marciniak,
Gianine E Delade,
Gianine E Thompkins,
Gianine E Tompkins,
Helen B Ricalde,
Helen Verdel,
Jacqueline Mdiaz Albertini,
Jason M Sluzynski,
Jean M Kelahan,
Jogy George,
Jose M Cayuela,
Jose V Obando,
Joseph F Mcginnis, RPh,
Joy Rkozlowski Klena,
Karen E D'orazio,
Kazi Rafiquzzaman,
Kelli F Dobilas,
Kelly Doremus,
Kinh Q Mac,
Li Li,
Liatte Kreuger, PharmD,
Melba Trivera Clavell,
Melissa A Zuppe,
Michael R Klapal,
Michael Serrano,
Nancy L Rolli,
Nikki S Ramirez,
Niraj Mehta,
Paul L Bellamy,
Peter R Lenahan,
Prabhu P Raju,
Regina T Brown,
Robert G Ruff,
Sandra Kershaw,
Sarah Adella Fave,
Sherri J Liu,
Sherry G Bous,
Shirley H Isbill,
Sidney B Priesmeyer,
Sinai Davis,
State Agency,
Stephen J Mottola,
Thomas J Arista,
Wayne J Meyer,
Wei Wang, PhD,
Xiuju Lu,
Yvesna C Blaise,
Zakaria I Ganiyu
Melba T Rivera's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2010 | FDA 483 | Genzyme Corporation - Form 483, 2010-12-21 |
February, 2011 | FDA 483 | Hoffmann La Roche Inc - Form 483, 2011-02-04 |
November, 2010 | EIR | Queseria Chipilo, Inc. - EIR, 2010-11-08 |
March, 2011 | FDA 483 | June Jacobs Labs, LLC - Form 483, 2011-03-21 |
August, 2011 | FDA 483 | Promeko, Inc. - Form 483, 2011-08-30 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more